Haemonetics Stock Story


USD 75.96  0.36  0.47%   

It looks as if Haemonetics Corp may not have a good chance to recover from the latest dip as its shares fell again. The company current daily volatility is 2.2 percent, with a beta of 0.99 and an alpha of 0.26 over DOW. As many baby boomers are still indifferent towards current volatility, Haemonetics Corp. We will evaluate why we are still optimistic in anticipation of a recovery.
Published over three months ago
View all stories for Haemonetics Corp | View All Stories

Is Haemonetics Corp (NYSE:HAE) stock way too aggressive for baby boomers?

Haemonetics Corp has roughly 236.88 M in cash with 105.76 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.64.
Our trade recommendations tool can be used to complement Haemonetics Corp advice provided by experts. It analyzes the entity's potential to grow against your specific risk preferences and investment horizon.
Investing in Haemonetics Corp, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Haemonetics Corp along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Haemonetics Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Haemonetics Corp in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Haemonetics Corp. Your research has to be compared to or analyzed against Haemonetics Corp's peers to derive any actionable benefits. When done correctly, Haemonetics Corp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Haemonetics Corp.

How important is Haemonetics Corp's Liquidity

Haemonetics Corp financial leverage refers to using borrowed capital as a funding source to finance Haemonetics Corp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Haemonetics Corp financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Haemonetics Corp's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Haemonetics Corp, but it might be worth checking our own buy vs. sell analysis

Haemonetics Corp Correlation with Peers

Investors in Haemonetics can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Haemonetics Corp. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Haemonetics Corp and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Haemonetics is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage.
Please check volatility of Haemonetics for more details

Breaking down Haemonetics Corp Indicators

Haemonetics Corp holds Efficiency (Sharpe) Ratio of -0.0931, which attests that the entity had -0.0931% of return per unit of risk over the last 3 months. Macroaxis standpoint towards determining the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Haemonetics Corp exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to check out Haemonetics Corp Downside Deviation of 2.7, market risk adjusted performance of 0.1456, and Risk Adjusted Performance of 0.068 to validate the risk estimate we provide.

Will Haemonetics Corp shareholders go ballistic after another dip?

Latest total risk alpha is at 0.44. Haemonetics Corp currently demonstrates below-average downside deviation. It has Information Ratio of 0.09 and Jensen Alpha of 0.26. However, we advise investors to further question Haemonetics Corp expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Haemonetics Corp's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Haemonetics Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Haemonetics Corp Implied Volatility

Haemonetics Corp's implied volatility exposes the market's sentiment of Haemonetics Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Haemonetics Corp's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Haemonetics Corp stock will not fluctuate a lot when Haemonetics Corp's options are near their expiration.

Although some other entities in the medical instruments & supplies industry are either recovering or due for a correction, Haemonetics Corp may not be performing as strong as the other in terms of long-term growth potentials. With an optimistic outlook on your 90 days horizon, it may be a good time to buy new shares of Haemonetics or increase your existing holdings in the Stock as it seems the potential growth has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Haemonetics Corp.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Haemonetics Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com